Real-World Study on the Efficacy of Mavacamten in Treating Obstructive Hypertrophic Cardiomyopathy: A Single-Center, Retrospective Cohort Study. (ChiCTR) - Sep 16, 2026 - P=N/A | N=25 | Not yet recruiting | Sponsor: Xiangya Hospital Central South University; Xiangya Hospital Central South University
New trial • Real-world evidence • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Obstructive Hypertrophic Cardiomyopathy
|